About us Newsletter News Widget Media Inquiries

Media Inquiries

Your experience will be better in the app

Install

Sign Up | Log In

Menu

Contact Us Terms of Service Support Privacy Policy Archive

© 2024 Otherweb

Follow

Featured Podcast EpisodesThe Other Web

Alex Fink

Zuckerman vs Zuckerberg

July 14, 2024

Ethan Zuckerman is a professor at the University of Massachusetts Amherst and a scholar of digital media. He and his team work to understand the contemporary digital world and build social media systems that are focused on communities, not on profits. Ethan is currently suing Meta (i.e. Facebook) in a landmark case that might (and likely should) change our interpretation of section 230. Please tune in to hear the details of the case and the various ways it could change the social media landscape. It's fascinating!

Prof. Jeff Jarvis - Rewriting Media's Business Model (Yet Again)

May 24, 2024

Jeff Jarvis is a journalism professor at the City College in New York (CUNY), the author of six books, and the cohost of the successful podcast "This week in Google and AI". Jeff spent many years teaching entrepreneurial journalism - and God knows journalism could use some entrepreneurial spirit, right about now. Please check out Jeff's books, The Gutenberg Parenthesis and Magazine, both from Bloomsbury (discount codes here: gutenbergparenthesis.com).

Donald Robertson - Where Philosophy Meets Psychology

June 22, 2024

Our guest today is Donald Robertson - Donald is a cognitive-behavioral psychotherapist and author of several books, including How to Think Like a Roman Emperor and, more recently, Marcus Aurelius: The Stoic Emperor. He is one of the founders of the Modern Stoicism nonprofit organization and the founder and president of the Plato's Academy Centre in Athens, Greece. He was born in Scotland but now lives in Montreal, Canada. His upcoming book, How to Think Like Socrates, will be released later this year, and can be preordered on Amazon, Barnes and Noble, or anywhere else books are generally sold.

Rick Edmonds - Analyzing the Financial Decline of Legacy Media

July 8, 2024

Rick Edmonds is the media business analyst for the Poynter Institute, a school and study center for working journalists. He has been doing research and writing for 25 years on the financial decline of legacy media, newspapers particularly, and the rise of new media alternatives. His reporting and commentary appear regularly on the Poynter Online site. He has spoken to conference groups in the U.S.A. and in Paris, Norway, Madrid, Vienna and Chile.

Jonathan Green - How To Make ChatGPT and Other Tools Useful (Right Now)

July 5, 2024

Welcome to the Otherweb. Our guest today is Jonathan Green - a bestselling author of hundreds of books, a celebrity ghostwriter, and an expert in using artificial intelligence tools to their utmost capacity. This is the best conversation I've had on the practical implications of ChatGPT and how regular people can augment their own capabilities by using these tools as a shortcut.

1h 4m

📌 Human Rights, War Escalates, More

Angela Palmer

•

TOP STORY

TOP STORY

Most countries fail to protect their citizens

WORLD

WORLD

Russia’s nuclear-capable missile escalates war

LAW

LAW

Kayaker faked his death and fled overseas

All Stories

Summary

Article Metadata

Long-term investors avoid short-term volatility

This is a news story, published by Yahoo Finance, that relates primarily to Pfizer news.

Pfizer news

For more Pfizer news, you can click here:

more Pfizer news

drug discoveries news

For more drug discoveries news, you can click here:

more drug discoveries news

Yahoo Finance news

For more news from Yahoo Finance, you can click here:

more news from Yahoo Finance

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about

current bull market

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest term investors news, market changes news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

The Motley Fool

The Motley Fool

•

2 Incredibly Cheap Growth Stocks to Buy Now

The Motley Fool

Summary

Nutrition label

78% Informative

Pfizer ( NYSE : PFE ) shares are trading down about 21% from their 52-week highs.

Pfizer remains a strong company, which means there is an opportunity for forward-thinking investors.

PayPal PayPal (NASDAQ: PYPL ) stock is up approximately 16% over the past 12 months ago but still remains down about 77% from its all-time high.

PayPal is expanding revenue at a healthy clip, increasing its cash flows, and remaining profitable.

Now could be a time to buy the stock while it's trading down considerably from its pandemic highs.

Consider when Nvidia made this list on April 15, 2005 ... if you invested $ 1,000 at the time of our recommendation, you’d have $ 769,685 !.

VR Score

76

Informative language

74

Neutral language

18

Article tone

semi-formal

Language

English

Language complexity

45

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

6

https://www.fool.com/investing/2024/08/05/what-is-carry-trade-japan-rate-hike-global-selloff/?utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=c1d84ae9-d1c2-46ed-974e-5ce050bf0843 https://www.fool.com/investing/2024/08/30/2-incredibly-cheap-growth-stocks-to-buy-now/?utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=c1d84ae9-d1c2-46ed-974e-5ce050bf0843 https://api.fool.com/infotron/infotrack/click?apikey=35527423-a535-4519-a07f-20014582e03e&impression=1fb747c1-991e-4d14-852d-15b6ccf67f2d&url=https%3A%2F%2Fwww.fool.com%2Fmms%2Fmark%2Fe-foolcom-sa-bbn-dyn%3Faid%3D8867%26amp%253Bsource%3Disaeditxt0010895%26ftm_cam%3Dsa-bbn-evergreen%26ftm_veh%3Darticle_pitch_feed_yahoo%26ftm_pit%3D13885&utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=c1d84ae9-d1c2-46ed-974e-5ce050bf0843 https://www.fool.com/author/20250/https://api.fool.com/infotron/infotrack/click?apikey=35527423-a535-4519-a07f-20014582e03e&impression=1fb747c1-991e-4d14-852d-15b6ccf67f2d&url=https%3A%2F%2Fwww.fool.com%2Fmms%2Fmark%2Fe-foolcom-sa-bbn-dyn%3Faid%3D8867%26source%3Disaeditxt0010895%26ftm_cam%3Dsa-bbn-evergreen%26ftm_pit%3D13885%26ftm_veh%3Darticle_pitch_feed_yahoo%26company%3DPfizer&utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=c1d84ae9-d1c2-46ed-974e-5ce050bf0843 https://www.fool.com/legal/fool-disclosure-policy/

Source diversity

2

www.fool.com api.fool.com

Affiliate links

no affiliate links

Read full article